Pfizer's Paxlovid Pill Gets Emergency Use Authorisation By US FDA For Oral Antiviral Treatment Of COVID-19
Pfizer’s Paxlovid pill on Wednesday got Emergency Use Authorisation by the US FDA for home treatment against COVID-19.
The Food and Drug Administration of the United States on Wednesday authorised Pfizer’s Paxlovid pill for home treatment against COVID-19. Paxlovid is the first pill against COVID-19 to get Emergency Use Authorisation (EUA) for oral antiviral treatment against the deadly virus. Notably, the drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited.
Tweet By Pfizer:
BREAKING: @US_FDA granted Emergency Use Authorization (EUA) for our novel #COVID19 oral #antiviral treatment for high-risk patients aged 12+ weighing at least 40 kg (88 lbs), marking another historic milestone in the fight against COVID-19. #ScienceWillWin https://t.co/IRocj16hV9 pic.twitter.com/6gTqzfKNhp
— Pfizer Inc. (@pfizer) December 22, 2021
(The above story first appeared on LatestLY on Dec 23, 2021 10:12 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
